Functional assessment of pancreatic beta-cell area in humans. - Wikidata - awgldk - TriplyDB

Functional assessment of pancreatic beta-cell area in humans.

Functional assessment of pancreatic beta-cell area in humans.

http://www.wikidata.org/entity/Q37236300

about

Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes Exercise as an intervention to improve metabolic outcomes after intrauterine growth restriction β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes.Administration of Melatonin and Metformin Prevents Deleterious Effects of Circadian Disruption and Obesity in Male Rats Utility of homeostasis model assessment of beta-cell function in predicting diabetes in 12,924 healthy Koreans.Analysis of factors influencing postprandial C-peptide levels in Japanese patients with type 2 diabetes: Comparison with C-peptide levels after glucagon load.Liraglutide is effective in type 2 diabetic patients with sustained endogenous insulin-secreting capacity.Utility of indices using C-peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes Defining criteria for the introduction of liraglutide using the glucagon stimulation test in patients with type 2 diabetes.Postprandial serum C-peptide value is the optimal index to identify patients with non-obese type 2 diabetes who require multiple daily insulin injection: Analysis of C-peptide values before and after short-term intensive insulin therapy.Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset Concordance of bioactive vs. total immunoreactive serum leptin levels in children with severe early onset obesity Age-corrected beta cell mass following onset of type 1 diabetes mellitus correlates with plasma C-peptide in humans Postprandial C-peptide to glucose ratio as a predictor of β-cell function and its usefulness for staged management of type 2 diabetes Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor, Improves Early-Phase Insulin Secretion in Drug-Naïve Patients with Type 2 Diabetes.Glucose Variability and β- Cell Response by GLP-1 Analogue added-on CSII for Patients with Poorly Controlled Type 2 Diabetes.Pancreatic volumetric assessment as a predictor of new-onset diabetes following distal pancreatectomy SPECT-OPT multimodal imaging enables accurate evaluation of radiotracers for β-cell mass assessments.β-Cell Deficit in Obese Type 2 Diabetes, a Minor Role of β-Cell Dedifferentiation and Degranulation.Human pancreatic β-cell G1/S molecule cell cycle atlas.C-Peptide-Based Index Is More Related to Incident Type 2 Diabetes in Non-Diabetic Subjects than Insulin-Based Index.Effects of Obesity and Diabetes on α- and β-Cell Mass in Surgically Resected Human Pancreas.The clinical utility of C-peptide measurement in the care of patients with diabetes Comparison of the Usefulness of the Updated Homeostasis Model Assessment (HOMA2) with the Original HOMA1 in the Prediction of Type 2 Diabetes Mellitus in Koreans Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes.Following the fate of the failing β-cell: new insights from first-phase insulin responses The nutritional management of type 3c (pancreatogenic) diabetes in chronic pancreatitis.OGTT 1h serum C-peptide to plasma glucose concentration ratio is more related to beta cell function and diabetes mellitus.Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis.To Evaluate the Effect of Edrophonium on Blood Glucose Levels in Euglycemic Albino Rats Through OGTT Role of reduced β-cell mass versus impaired β-cell function in the pathogenesis of type 2 diabetes.The effects of liraglutide on both hypereosinophilic insulin allergy and the characteristics of anti-insulin antibodies in type 2 diabetes mellitus: a case report.Improved diabetes control and pancreatic function in a type 2 diabetic after omeprazole administration.Prediction of Diabetes Using Serum C-Peptide.Relationship between fractional pancreatic beta cell area and fasting plasma glucose concentration in monkeys.Evaluation of PET Brain Radioligands for Imaging Pancreatic β-Cell Mass: Potential Utility of 11C-PHNO.Metformin and β-cell function in insulin-treated patients with type 2 diabetes: A randomized placebo-controlled 4.3-year trial.Islet Volume and Indexes of β-Cell Function in Humans.Assessment of beta-cell function in young patients with type 2 diabetes: arginine-stimulated insulin secretion may reflect beta-cell reserve.Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans.

P2860

Q26747696-F637D528-0B79-44EB-8DE6-CD420756B9A6 Q27021167-13DFBC64-98B1-4556-9750-440728D7F78A Q27692665-BEFCBF3F-A72F-4453-B721-ACF4F11B4269 Q28395600-742DE73F-57B9-4473-AE02-FA9BCD9F1A25 Q33556817-9E24430F-C650-4E77-84CD-8E34015578DD Q33585549-FEED5112-BD17-445F-8FCF-63FD659B67F3 Q33585774-6AE86F17-AF33-4877-9CED-FE183CBE267F Q33585873-6CF25CE0-36B5-4A77-92C0-5B270FEBF564 Q33607736-5FA442F8-2691-4373-B9CA-FEAE018D0A79 Q33607770-E4E4A33F-E720-4646-9328-468FEB2FF92F Q33688616-84095A28-057F-4699-9A3B-95BE79C1473D Q33718974-FC9FFF15-E495-43F2-A2F7-8160BCBD8A9F Q34071649-82F8FC3C-6FAA-4059-8332-C4F5B6F492A5 Q34299622-A5EEF18F-AEF1-435D-9883-36AD5339DC43 Q36031120-57677EEA-120D-4813-B282-0DCEFADB309B Q36320582-22327309-31E6-4844-BB68-A7A6BF7D7C4C Q36428692-13564779-C25D-45B5-9606-A0AE635D06C3 Q36799526-71DB44C4-A9D0-4F68-BA8B-DEF2A9873264 Q36935392-A8169CFC-689D-4805-80E9-BFB844351ADE Q37014986-C95E4AD5-6031-4D06-99CE-861C1BE102D8 Q37043642-BC97E6F3-729D-4AC1-907C-83CE329C7484 Q37057949-AD4B7727-4EDC-49C7-8E0B-652C7CFD6750 Q37108880-69A1E936-22AE-40E3-9E89-8C66419A3635 Q37198163-4A3234A4-9A07-41C8-8EBC-5DF0C81B3491 Q37231868-7B5E4A8D-1F22-48EC-A5B2-B6AE45D76C66 Q37333539-EF2E2622-B72F-4E92-91AB-61D3E6458B0A Q38894318-285655DA-93FB-4C52-BAE3-501C176BD5CE Q41613032-2C83F81D-3FC6-440D-A29E-2BBBF372AFAB Q41689680-E807EECE-80A1-4777-9CCE-0B5135825044 Q41905318-4B9023A9-C43C-4D02-A8A8-1CAD0218E141 Q41945969-34D49399-C40C-4501-9D6D-1B90F6BEAE3A Q42118961-2EB9CBB9-2AE4-4678-B4AD-40048BF7A095 Q42160579-B4CB6D20-6CA0-40EE-9FE4-0C4F8F906E56 Q42532272-F2F0F9E1-FBAD-4105-90AF-5933A0F7C0C7 Q42959228-65D6C060-CEC9-4B7B-80D9-79E1965ADE08 Q47839163-375F9DEE-3020-4AAE-A014-CCF5FDA41317 Q48261738-40EE5142-3755-410A-B0CD-242AC4089C2D Q51300949-7CB67F20-2BA3-46EA-B27A-99BBF6ED31E9 Q51327644-2D3BF50D-AA9D-44B0-B114-557787AB48C4 Q51361913-AEACD032-2AF7-4000-AEB4-5A5D35C8A14B

P2860

Functional assessment of pancreatic beta-cell area in humans.

http://www.wikidata.org/entity/Q37236300

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Functional assessment of pancreatic beta-cell area in humans.

@en

Functional assessment of pancreatic beta-cell area in humans.

@nl

type

label

Functional assessment of pancreatic beta-cell area in humans.

@en

Functional assessment of pancreatic beta-cell area in humans.

@nl

prefLabel

Functional assessment of pancreatic beta-cell area in humans.

@en

Functional assessment of pancreatic beta-cell area in humans.

@nl

P1433

Q37236300-89E868B6-3A21-46B2-8F74-F0484D9D7B35

P1476

Q37236300-1612384E-925F-43AF-AF50-AD5659C80D7E

P2093

Q37236300-017FB1D3-167F-4CE5-9F0C-7B95CE5A08AE

Q37236300-182B67DE-397B-4285-B265-D683A4C8E502

Q37236300-250E31D1-0B13-4474-9793-3562A9C6950B

Q37236300-2E00694E-E178-42B2-8C20-0B96877AA48F

Q37236300-300ABABF-9DC2-413C-87DE-32C149C3BE0B

Q37236300-45A23DF4-EA43-4B47-B8A1-7C2079D7CDF1

Q37236300-5D08F385-4653-46F4-B91D-913F5DDD8979

Q37236300-BC19154E-7B74-4B2E-BE07-97332AD350A9

P2860

Q37236300-040B7306-0270-4575-9F29-E3B3C3487D07

Q37236300-1128A28F-BC58-4CBC-A6FD-9544F16DC38D

Q37236300-15A6B1A5-0D48-4CFC-AEE1-DD7D383E04A1

Q37236300-1A4B4820-C5C8-4B18-A0E1-DEFAEE3BBCD4

Q37236300-1BE3E353-6AA9-4F34-BA2A-633DDC02C041

Q37236300-26E63264-DF64-4060-B9BC-7090DEBE7DB2

Q37236300-36523A39-6A6F-4E81-94A0-CF5C5AF9D564

Q37236300-371F83D5-5321-40AE-BF44-11E99A60D44A

Q37236300-379994EA-730A-49FA-B09D-3A2497ABE4D6

Q37236300-3CA5F9D4-1D38-4988-BBEF-AA5818B4F118

P304

Q37236300-6B419AE7-8075-4FFB-83EE-D4C428A94004

P31

Q37236300-EDFDE799-1D86-4931-8E4C-B7F44E1A5079

P356

Q37236300-4A7B5D8C-E237-47E4-968D-B5DDF85A007F

P407

Q37236300-CEF436FB-AA67-466A-8441-F6EBFAF10AC4

P433

Q37236300-BD1875F9-7D35-4DDB-B329-0C23CF295B82

P478

Q37236300-F7A0538D-7817-4715-86D6-34F28A558038

P577

Q37236300-C01604AA-B4A4-4921-BD52-E637195CCB28

P5875

Q37236300-7DA3D312-0DAD-4EAF-AF5D-13CF595CD334

P698

Q37236300-319B725F-4019-41A3-9AC6-16E8934DF3B7

P932

Q37236300-5ADAE994-B117-4081-869E-04E056AD30C7

P356

P1433

P1476

Functional assessment of pancreatic beta-cell area in humans.

@en

P2093

Andrea Tannapfel

http://www.w3.org/2001/XMLSchema#string

Bjoern A Menge

http://www.w3.org/2001/XMLSchema#string

Christophe A Müller

http://www.w3.org/2001/XMLSchema#string

Henning Schrader

http://www.w3.org/2001/XMLSchema#string

Juris J Meier

http://www.w3.org/2001/XMLSchema#string

Thomas G K Breuer

http://www.w3.org/2001/XMLSchema#string

Waldemar Uhl

http://www.w3.org/2001/XMLSchema#string

Wolfgang E Schmidt

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

Successful islet transplantation: continued insulin reserve provides long-term glycemic control.

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled tr

Report of the expert committee on the diagnosis and classification of diabetes mellitus.

On the track to the beta-cell.

Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus

Follow-up report on the diagnosis of diabetes mellitus.

Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosis.

P304

1595-1603

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB08-1611

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26278598

http://www.w3.org/2001/XMLSchema#string

P698

19509022

http://www.w3.org/2001/XMLSchema#string

P932

2699865

http://www.w3.org/2001/XMLSchema#string